We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Review Amendment Passes House, Faces Obstacles in Senate
Drug Review Amendment Passes House, Faces Obstacles in Senate
May 26, 2006
While the House bucked both the White House and the FDA in passing two controversial drug policy measures late May 23, the Senate seems less likely to agree to the provision regarding drug advisory boards.